Ubs Group Ag Grifols Sa Call Options Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
Call Options
1 transactions
Others Institutions Holding GRFS
# of Institutions
169Shares Held
153MCall Options Held
76.5KPut Options Held
106K-
Brandes Investment Partners, LP La Jolla, CA25.7MShares$277 Million1.99% of portfolio
-
Capital World Investors Los Angeles, CA21.5MShares$232 Million0.03% of portfolio
-
Permian Investment Partners, LP New York, NY18.1MShares$195 Million23.98% of portfolio
-
Black Creek Investment Management Inc. Toronto, A612.7MShares$137 Million4.37% of portfolio
-
Armistice Capital, LLC New York, NY9.28MShares$100 Million1.01% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $7.32B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...